About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 655 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 655 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 341-360 of 655 trials

CompletedInterleukin-12 in Treating Patients With Cancer in the AbdomenRATIONALE: Interleukin-12 may kill tumor cells by stimulating a person's white blood cells to kill cancer cells.NCT00003046·Houston, Texas CompletedNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in participants with surgically removed pancreatic cancer who then take…NCT01964430·Scottsdale, Arizona and 340 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSafety Study of CALAA-01 to Treat Solid Tumor CancersRationale: CALAA-01 is a targeted therapeutic designed to inhibit tumor growth and/or reduce tumor size. The active ingredient in CALAA-01 is a small interfering RNA (siRNA).NCT00689065·Duarte, California and 2 others

RecruitingPancreatic Cancer Early Detection ConsortiumThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal…NCT04970056·Phoenix, Arizona and 59 others

CompletedA Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advanced GI malignancies.NCT05039177·Birmingham, Alabama and 13 others

CompletedACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsACE1702 (anti-HER2 oNK cells) is an off-the-shelf Natural Killer (NK) cell product that targets human HER2-expressing solid tumors.NCT04319757·Chicago, Illinois and 2 others

CompletedStudy Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer PatientsThis study will assess the efficacy and safety of BL-8040 in combination with pembrolizumab (Keytruda®) and BL-8040/ Pembrolizumab in combination with liposomal irinotecan…NCT02826486·Phoenix, Arizona and 30 others

CompletedTrial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaOpen-label, dose-escalating, Phase IIa trial of NanoPac® to treat subjects with locally advanced pancreatic adenocarcinoma via direct intratumoral injection.NCT03077685·Los Angeles, California and 3 others

TerminatedA Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)This is a study evaluating the efficacy, safety, and pharmacokinetics of zilovertamab vedotin in participants with metastatic solid tumors including previously treated cancers of…NCT04504916·Hollywood, Florida and 13 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 38 others

TerminatedSafety Study of SEA-CD40 in Cancer PatientsThis study is being done to find out if SEA-CD40 is safe and effective when given alone, in combination with pembrolizumab, and in combination with pembrolizumab, gemcitabine, and…NCT02376699·Birmingham, Alabama and 18 others

RecruitingA Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsThe purpose of the study is to explore the safety and effects of the study drug (PF-08046876) in people diagnosed with advanced cancer of the bladder, lung, head and neck…NCT07090499·Duarte, California and 30 others

CompletedAdagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 in combination with TNO155 in patients with advanced solid…NCT04330664·Los Angeles, California and 16 others

CompletedAPRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic CancerThis study will compare the anti-tumor efficacy of apricoxib and gemcitabine/erlotinib with placebo and gemcitabine/erlotinib in patients with advanced pancreatic cancer.NCT00709826·Tucson, Arizona and 38 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedPhase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the PancreasPhase III Metastatic Pancreatic CancerNCT00844649·Birmingham, Alabama and 192 others

CompletedGenistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00376948·Detroit, Michigan and 1 other

RecruitingPhase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsThis is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to…NCT07145255·San Francisco, California and 6 others

RecruitingEffect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsThis study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA.NCT04373564·Scottsdale, Arizona and 50 others

Active not recruitingEarly Detection Initiative for Pancreatic CancerThe Early Detection Initiative for Pancreatic Cancer is a multi-center prospective study to determine if algorithm-based screening in patients with glycemically defined new onset…NCT04662879·Pasadena, California and 1 other

PreviousPage 18 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia